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j ourna l homepage: www.eb iomed ic ine.comEditorialAutism: Fitting the Pieces TogetherTheUnitedNation declaredApril 2 asWorld AutismAwarenessDay in
2007, to highlight the need to help improve the lives of children and
adultswith autism. TheAutismSociety of AmericamarksApril asNational
Autism Awareness Month, while in the UK, from March 27 to April 2,
2015, the National Autistic Society also holds World Autism Awareness
Week with the campaign “Stand Out for Autism”. These events are to
raise public awareness of this lifelong developmental condition that can
affect the way a person communicates with and relates to others, as
well as how they make sense of the world. Not only might autism nega-
tively impact the quality of life of affected individuals and their caregivers,
but providing the healthcare, social care and education that individuals
need and deserve is also costly.
Autism prevalence has increased substantially from 1 in 2500 in the
1980s when autism was ﬁrst included in DSM-III to 1 in 100 at present.
This increase can in part be attributed to a number of factors, including
early detection, increased awareness, and broadening of the deﬁnition
from the original entity ﬁrst described by Kanner in 1943 to include so-
called autistic spectrum disorders. Autism can be diagnosed at 2–
3 years of age, and affected individuals usually have a normal lifespan.
This puts autism on the same magnitude in terms of patient years with
one of the most prevalent neurological disorders—Alzheimer's disease.
There is no known cure for autism; however, there are many
approaches and forms of support that can help people with autism to
manage their condition and fulﬁl their potential. Successful management
can depend on early diagnosis and behavioral and educational therapies.
While medication (e.g., antipsychotics) does not address the core neuro-
logical issues associatedwith autism, it can helpwithmental health prob-
lems such as anxiety and depression and treat other behaviors such as
aggression. There is a clear unmet need in autism management due to a
lack in basic understanding of deﬁnitive causative factors, how they lead
to autism, and whether any of themmay be amenable to interventions.
Dating back nearly 40 years to the work of Folstein and Rutter, family
and twin studies have demonstrated a highly heritable component
to autism, evident by high concordance rate in mono- and di-zygotic
twins. Given this genetic predisposition, signiﬁcant efforts have been
made in identifying autism risk genes. Geneticists have levered
genome-wide and candidate gene approaches and have linked dozens
of gene variants to autism; however, no single locus accounts for more
than 1% of cases. Some of these genes have a role in neuronal synaptic ac-
tivities. These genes also affect other neurological and psychiatric disor-
ders and not just autism. Nevertheless, the fact that autism can
sometimes run in families suggests strong genetic risk factor(s) yet to
be pinpointed. Exposure to environmental factors (e.g., certain drugs
and toxins during early pregnancy) has also been implicated to increase
the risk of developing autism in the newborn. However, research in this
area is difﬁcult due to a large number of variables that need to be con-
trolled for; hence the results to date are not conclusive.http://dx.doi.org/10.1016/j.ebiom.2015.03.014
2352-3964/© 2015 Published by Elsevier B.V.With the aid of advanced imaging techniques, neurobiologists have
made important breakthroughs in understanding brain structures and
functions in autism. Neuroimaging studies have shown excessive brain
growth during the ﬁrst 2 years of life in 20–30% of autistic children.
There are also structural abnormalities in the autistic brain; however
many of themare of unknown clinical signiﬁcance. Is autism therefore as-
sociated more with brain function than brain morphology? Functional
MRI reveals that, compared with normal controls, people with autism
use different brain areas for object and human face recognition. In adults
with autism, there appears to be a long-distance under-connectivity and
short-range over-connectivity in the brain, although this observation is
less clear in children. This ‘miswiring’ could result in a lack of integration
between brain regions and ineffective information processing. As the
brain is highly plastic and capable of making new synaptic connections
and changing the strength of such connections, especially in early life,
this ‘miswiring’ may in theory be ameliorated with behavioral therapy,
brain stimulation andpractice, and the treatment success is highly depen-
dent on early and accurate diagnosis of autism.
Studies from other science disciplines have also shown that biochem-
ically, children with autism can have reduced antioxidant capacity thus
may have chronic oxidative stress, which could lead to neuron dysfunc-
tion and affect synaptic plasticity, learning and memory. Immunological-
ly, autism individuals may overexpress pro-inﬂammatory cytokines.
Other proposed biomarkers include low levels of oxytocin, increased
levels of platelet serotonin, and reduced levels of plasma growth factors.
Can all of these seemingly unconnectedﬁndings be the result of the inter-
play between genetic and environmental factors?
The possible interconnections among different factors in autismpatho-
genesis highlight the importance of a multidisciplinary approach, where
psychologists, psychiatrists, neurobiologists, geneticists, immunologists,
biochemists as well as bioinformaticians should come together, pool
their resources and analyze the available data. A clear priority should be
to deﬁnemolecular signaling pathways in the developing brain for normal
cognitive and motor development, language ability and social interaction.
The next hurdle is to delineate the molecular, cellular and neurobiological
factors, or combinations of those factors, that may be responsible for the
pathogenesis of autism, then to identify factors that may be amendable
to interventions. Transforming big data into new insights requires parallel
computational studies, preclinical in vivo testing, and clinical and valida-
tion trials—all of which when done in concert should strengthen one an-
other and hopefully lead us to a solution for our autism puzzle. Beyond
this and perhaps even more importantly, these new insights can help us
understand and appreciate the differences in social cognition, language
and behavior from the perspective of individuals with autism, and ﬁnd ef-
fective ways to empower them to have a role in the society.
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